Cryoport’s (CYRX) Logistics Solution to Support Stemedica’s Ischemic-Tolerant … – StreetInsider.com
|
Cryoport's (CYRX) Logistics Solution to Support Stemedica's Ischemic-Tolerant …
StreetInsider.com Cryoport (NASDAQ: CYRX) announced that its validated cryogenic logistics solution is supporting the worldwide distribution of Stemedica's ischemic-tolerant stem cell product lines. Stemedica Cell Technologies, Inc. ("Stemedica") develops and … |
